Orphan Europe, part of the Recordati Group, is a pharmaceutical company that develops and distributs orphan drugs for the treatment of rare diseases. Whether you are a physician seeking help and support in your fight to treat a rare disease, a patient looking for information or a company looking for a partnership – Orphan Europe is waiting to hear from you.
| | | | MIDDLE EAST MAJOR EVENT The 11/02/2009 at 10:26:10
The 5th MEMG MEETING
LEBANON 19-21 February 2009
Read the news >> | | | | |
|
|
| | | | Orphan Europe and CMIC sign a Collaboration AgreementNews The 22/12/2008 at 16:15:13
Paris, France and Tokyo, Japan, 16th December 2008.
Orphan Europe SARL and CMIC Co., Ltd. have signed a Collaboration and License Agreement regarding the development, registration and marketing of Normosang® (human hemin) for the treatment of acute attacks of hepatic porphyria in the Japanese market.
Read the news >> | | | | |
|
Orphan Europe provides treatment for patients suffering from rare diseases all over the world. Read more about the different diseases here.
|
|
|
|
Orphan Europe has been developing and distributing orphan drugs since 1990 and has today an extensive product portfolio. Read more about some of the orphan medicinal products provided by Orphan Europe.
|
|
|
|
Provides high-quality, innovative science education for healthcare personnel involved in the diagnosis and management of patients affected by rare diseases.
|
|
|
|
